{"uid":"cap_pVRADHJ72uk7vwuDRc_qh","slug":"medicare-part-d-prescriber-adoption-feed-govparse-791c6ada","name":"Medicare Part D Prescriber Adoption Feed (GovParse)","description":"Which prescribers just entered a drug class this Medicare Part D year — e.g. new GLP-1 prescribers in PY2024? Bulk feed over CMS Part D Prescribers by Provider and Drug, aggregated per NPI to a drug class and differenced PY2023 → PY2024: direction=new_entrant returns new-to-class prescribers, de_adopter those whose class volume fell. Flat rows, cursor-paginated up to 1000/page, by drug_class, specialty, and state. Observational public Part D records — never a clinical recommendation.","url":"https://api.govparse.io/v1/feeds/pharma-prescribing","method":"GET","headers":{},"bodySchema":{"type":"object","$schema":"https://json-schema.org/draft/2020-12/schema","properties":{"input":{"type":"object","required":[],"properties":{"limit":{"type":"integer","examples":[500],"description":"Rows per page (default 500, cap 1000)."},"state":{"type":"string","examples":["TX"],"description":"Prescriber state code (two letters)."},"cursor":{"type":"string","examples":["eyJvIjo1MDB9"],"description":"Opaque page cursor — pass the previous page's next_cursor unchanged."},"direction":{"type":"string","examples":["new_entrant"],"description":"new_entrant (default; wrote the class in PY2024 with ≤ max_prior_claims in PY2023 — the new-to-class buying moment) | de_adopter (class volume fell ≥ min_pct_drop%)."},"specialty":{"type":"string","examples":["Endocrinology"],"description":"Prescriber specialty (Prscrbr_Type), e.g. Endocrinology."},"drug_class":{"type":"string","examples":["GLP-1"],"description":"Therapeutic drug class: GLP-1 | SGLT2 | DPP-4 | Statin. Default GLP-1."},"min_pct_drop":{"type":"integer","examples":[50],"description":"de_adopter only: minimum percent decline in class volume PY2023 → PY2024."},"min_claims_2024":{"type":"integer","examples":[50],"description":"Minimum class claims in PY2024."},"max_prior_claims":{"type":"integer","examples":[0],"description":"new_entrant only: maximum PY2023 class claims allowed (0 = truly new to the class)."}}}}},"responseSchema":null,"example":null,"exampleRequest":null,"tags":["x402"],"displayCostAmount":"25","displayCostAsset":"USDC","priceDynamic":false,"priceHint":null,"priceStatus":"priced","priceSource":"probe","requiresHandshake":false,"reviewCount":0,"rating":{"score":"0.00","successRate":"0.00","reviews":0,"stars":null,"state":"unrated"},"availabilityStatus":"unknown","priceObserved":null,"sessionDeposit":null,"pricing":{"kind":"static","summary":"$25/call","primary":{"kind":"static","protocol":"x402","network":"base","amountUsd":"25","per":"call","confidence":"exact"},"accepted":[{"kind":"static","protocol":"x402","network":"base","amountUsd":"25","per":"call","confidence":"exact"}]},"paymentMethods":[{"uid":"pm_v6okTsqGLI-quT02uy-kQ","protocol":"x402","methodType":"crypto","chain":"base","mode":"charge","costAmount":"25","costPer":"request","priority":0,"asset":"0x833589fCD6eDb6E08f4c7C32D4f71b54bdA02913","unit":"request","depositMicros":null,"planRef":null}],"brandName":null,"brandSlug":null,"brandBaseUrl":null,"brandDocsUrl":null,"whatItDoes":"Returns bulk paginated rows of Medicare Part D prescribers who newly entered or de-adopted a drug class (e.g. GLP-1, SGLT2) between PY2023 and PY2024, filterable by drug class, specialty, and state.","exampleAgentPrompt":"Pull the first 500 new GLP-1 prescribers in Texas for Medicare Part D PY2024 — endocrinologists only, with zero prior claims in PY2023 so they're truly new to the class.","exampleUseCases":[{"title":"Pharma sales rep territory targeting","prompt":"Give me a list of new GLP-1 prescribers in California for PY2024 who had zero prior GLP-1 claims in 2023 — I want endocrinologists and primary care, up to 1000 rows, so my sales team can prioritize outreach."},{"title":"Market research on GLP-1 de-adoption","prompt":"Which Medicare Part D prescribers dropped their GLP-1 prescribing volume by at least 50% from PY2023 to PY2024 in New York? I need specialty and NPI so I can understand where the class is losing traction."},{"title":"Competitive intelligence on SGLT2 class entry","prompt":"Show me all new SGLT2 prescribers in Florida for PY2024 — cardiologists specifically — with at least 50 claims in 2024 and no more than 5 prior claims in 2023, paginated 500 at a time."}],"resultDescription":"Flat paginated rows (up to 1000 per page) of prescribers with NPI, specialty, state, drug class, PY2023 and PY2024 claim volumes, and a direction label (new_entrant or de_adopter). Includes a next_cursor field for fetching subsequent pages. Data is derived from public CMS Medicare Part D records and is observational only.","failureModes":["Invalid drug_class value returns an error or empty results — must be one of GLP-1, SGLT2, DPP-4, Statin","Invalid two-letter state code returns empty results or validation error","min_pct_drop ignored when direction=new_entrant; max_prior_claims ignored when direction=de_adopter","Cursor token from a different query or expired session returns an error or unexpected page","limit above 1000 is capped silently at 1000","Payment failure (x402) blocks access entirely before any data is returned"],"whenToPreferThis":"Choose this endpoint when you need a bulk, filterable feed of Medicare Part D prescribers segmented by drug class adoption behavior (new entrants or de-adopters) across PY2023→PY2024. It is purpose-built for pharmaceutical sales targeting, market research, and competitive intelligence use cases that require NPI-level granularity, specialty filtering, and state-level segmentation — rather than a single prescriber lookup.","instructions":null,"reviewSummary":null,"reviewSummaryHighlights":null,"reviewSummaryConcerns":null,"reviewSummaryGeneratedAt":null,"activationCount":0,"lastUsedAt":null,"lastSuccessfullyRanAt":null,"lastHealthCheckAt":"2026-09-15T00:32:02.997Z","isFirstParty":false}